Literature DB >> 9618733

Pricing and reimbursement of pharmaceuticals. A new culture for the community pharmacist.

E Moen1, E L Toverud, J Grund, S Brinchmann.   

Abstract

Pricing and reimbursement of pharmaceuticals are of concern for pharmacists. Different countries have different ways of organising their health care systems. The place for pharmaceuticals within these systems also differ. This article looks into the price- and reimbursement systems for medicinal products in Germany, Sweden, the UK and Norway. Various ways of organising the pharmaceutical market emerge. Some existing measures have been in place for a long time while others have been introduced more recently. A common goal for the four countries seems to be the drive to cut costs, and attempts to do this can be directed through various reimbursement systems, by focusing on prices or by influencing the physicians' prescribing behaviour, either through the use of advice or through the use of budgets. It is important for the pharmacists to have in-depth knowledge of the price- and reimbursement system they have to work within in order to be of full service to their customers.

Mesh:

Substances:

Year:  1998        PMID: 9618733     DOI: 10.1023/a:1008651106315

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  6 in total

1.  Recent public policies in The Netherlands to control pharmaceutical pricing and reimbursement.

Authors:  H Rigter
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

2.  The role of pharmacoeconomics in health policy and management in Norway.

Authors:  J Grund; H Husbyn
Journal:  Pharmacoeconomics       Date:  1995-06       Impact factor: 4.981

3.  Lessons from international experience in controlling pharmaceutical expenditure. II: Influencing doctors.

Authors:  K Bloor; N Freemantle
Journal:  BMJ       Date:  1996-06-15

4.  Lessons from international experience in controlling pharmaceutical expenditure. III: Regulating industry.

Authors:  K Bloor; A Maynard; N Freemantle
Journal:  BMJ       Date:  1996-07-06

5.  The German health care system at the crossroads.

Authors:  J M vd Schulenburg
Journal:  Health Econ       Date:  1994 Sep-Oct       Impact factor: 3.046

6.  Effect of NHS reforms on general practitioners' referral patterns.

Authors:  A Coulter; J Bradlow
Journal:  BMJ       Date:  1993-02-13
  6 in total
  2 in total

1.  Pricing and reimbursement of pharmaceuticals in the Czech Republic and Sweden.

Authors:  Jana Davidova; Lenka Praznovcova; Cecilia Stålsby Lundborg
Journal:  Pharm World Sci       Date:  2007-06-23

2.  Financial perspective of private pharmacies in Tehran (Iran); is it a lucrative business?

Authors:  Khosro Keshavarz; Abbas Kebriaeezadeh; Amir Hashemi Meshkini; Shekoufeh Nikfar; Iman Mirian; Hasan Khoonsari
Journal:  Daru       Date:  2012-10-22       Impact factor: 3.117

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.